DATA GRAPHICS | Data Byte
Why, hello there: biotech looking up in 3Q
Two weeks in, NBI, XBI outperforming NASDAQ
July 16, 2022 1:20 AM UTC
Two weeks into 3Q22 and the NASDAQ Biotechnology index and the SPDR S&P Biotech ETF are so far outperforming the NASDAQ Composite. The XBI, which ended 2Q down the most of the group at -33.7% year-to-...